INNOVATIVE CLINICAL SOLUTIONS LTD
10-Q, EX-27, 2000-12-21
MISC HEALTH & ALLIED SERVICES, NEC
Previous: INNOVATIVE CLINICAL SOLUTIONS LTD, 10-Q, 2000-12-21
Next: MADGE NETWORKS NV, 6-K, 2000-12-21



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>              <C>             <C>            <C>            <C>
<PERIOD-TYPE>                   9-MOS            OTHER           OTHER          3-MOS          2-MOS
<FISCAL-YEAR-END>               JAN-31-2000      JAN-31-2001     JAN-31-2001    JAN-31-2000    JAN-31-2001
<PERIOD-START>                  FEB-01-1999      FEB-01-2000     SEP-21-2001    AUG-01-1999    AUG-01-2000
<PERIOD-END>                    OCT-31-1999      SEP-20-2000     OCT-31-2000    OCT-31-1999    SEP-20-2000
<CASH>                               38,017                0           7,891         38,017              0
<SECURITIES>                              0                0               0              0              0
<RECEIVABLES>                        47,684                0          14,621         47,684              0
<ALLOWANCES>                       (19,690)                0         (2,204)       (19,690)              0
<INVENTORY>                               0                0               0              0              0
<CURRENT-ASSETS>                     99,302                0          24,159         99,302              0
<PP&E>                               15,387                0          10,502         15,387              0
<DEPRECIATION>                      (4,035)                0         (4,449)        (4,035)              0
<TOTAL-ASSETS>                      158,927                0          92,061        158,927              0
<CURRENT-LIABILITIES>                47,617                0          40,640         47,617              0
<BONDS>                             100,000                0               0        100,000              0
                     0                0               0              0              0
                               0                0               0              0              0
<COMMON>                                320                0             120            320              0
<OTHER-SE>                            3,879                0          48,478          3,879              0
<TOTAL-LIABILITY-AND-EQUITY>        158,927                0          92,061        158,927              0
<SALES>                             154,887           65,755           8,942         44,371         14,307
<TOTAL-REVENUES>                    154,887           65,755           8,942         44,371         14,307
<CGS>                                     0                0               0              0              0
<TOTAL-COSTS>                             0                0               0              0              0
<OTHER-EXPENSES>                    198,570           87,607          10,191         52,150         18,335
<LOSS-PROVISION>                          0                0               0              0              0
<INTEREST-EXPENSE>                    6,925            4,616             153          2,207          (245)
<INCOME-PRETAX>                    (50,608)         (26,468)         (1,402)        (9,986)        (4,273)
<INCOME-TAX>                             47            1,456               0           (53)          1,502
<INCOME-CONTINUING>                (50,655)         (27,924)         (1,402)        (9,933)        (5,775)
<DISCONTINUED>                            0                0               0              0              0
<EXTRAORDINARY>                    (49,632)          100,000               0              0        100,000
<CHANGES>                                 0                0               0              0              0
<NET-INCOME>                      (100,287)           72,076         (1,402)        (9,933)         94,225
<EPS-BASIC>                          (2.79)                0           (.12)         (0.28)              0
<EPS-DILUTED>                        (2.79)                0           (.12)         (0.28)              0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission